Latest Regulatory Breach News

Page 2 of 2

Avecho Addresses ASX Price Query Amid Speculation on CBD Trial Milestone

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Ada Torres

14 Feb 2025

Epsilon Healthcare Board Turmoil Amid Growth in Manufacturing and Clinics

Epsilon Healthcare's December 2023 quarterly report reveals significant boardroom conflict and governance breaches, yet operational segments show promising growth.

Ada Torres

31 Jan 2025